Enabling capillary wicking on bulk metal alloys is challenging due to processing complexity at different size scales. This work presents a laser-chemical surface treatment to fabricate superwicking patterns guided by a superhydrophobic region over a large-area metal alloy surface. The laser-chemical surface treatment generates surface micro/nanostructures and desirable surface chemistry simultaneously. The superhydrophobic surface was first fabricated over the whole surface by laser treatment under water confinement and fluorosilane treatment; subsequently, superwicking stripes were processed by a second laser treatment in air and cyanosilane treatment. The resultant surface shows superwicking regions surrounded by superhydrophobic regions. During the process, superwicking regions possess dual-scale structures and polar nitrile surface chemistry. In contrast, random nanoscale structures and fluorocarbon chemistry are generated on the superhydrophobic region of the aluminum alloy 6061 substrates. The resultant superwicking region demonstrates self-propelling anti-gravity liquid transport for methanol and water. The combination of the capillary effect of the dual-scale surface microgrooves and the water affinitive nitrile group contributes toward the self-propelling movement of water and methanol at the superwicking region. The initial phase of wicking followed Washburn dynamics, whereas it entered a non-linear regime in the later phase. The wicking height and rate are regulated by microgroove geometry and spacing.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414485PMC
http://dx.doi.org/10.1021/acsami.1c09144DOI Listing

Publication Analysis

Top Keywords

surface treatment
12
surface
11
metal alloys
8
laser-chemical surface
8
superhydrophobic region
8
surface chemistry
8
laser treatment
8
superwicking regions
8
superwicking region
8
phase wicking
8

Similar Publications

Background: Transient receptor potential cation channel subfamily V member 2 (TRPV2) functions as a stretch-sensitive calcium channel, with overexpression in the sarcolemma of skeletal and cardiac myocytes leading to detrimental calcium influx and triggering muscle degeneration. In our previous pilot study, we showed that tranilast, a TRPV2 inhibitor, reduced brain natriuretic peptide levels in two patients with muscular dystrophy and advanced heart failure. Building on this, we performed a single-arm, open-label, multicenter study herein to evaluate the safety and efficacy of tranilast in the treatment of advanced heart failure in patients with muscular dystrophy.

View Article and Find Full Text PDF

Background: Microsatellite instability-high (MSI-H) metastatic colorectal cancer (CRC) patients are the dominant population in immune checkpoint blockade treatments, while more than half of them could not benefit from single-agent immunotherapy. We tried to identify the biomarker of MSI-H CRC and explore its role and mechanism in anti-PD-1 treatments. Tumor-specific MHC-II was linked to a better response to anti-PD-1 in MSI-H CRC and CD74 promoted assembly and transport of HLA-DR dimers.

View Article and Find Full Text PDF

Background: Local relapse has not been eradicated even in the era of total mesorectum excision. Although various approaches have been attempted, R0 resection remains the only potentially curative treatment. PATIENT AND METHODS: A 45-year-old woman with a history of laparoscopic abdominoperineal resection was diagnosed with pelvic recurrence 7 months ago.

View Article and Find Full Text PDF

Adoptive cell therapies (ACT) have shown reduced efficacy against solid tumor malignancies compared to hematologic malignancies, partly due to the immunosuppressive nature of the tumor microenvironment (TME). ACT efficacy may be enhanced with pleiotropic cytokines that remodel the TME; however, their expression needs to be tightly controlled to avoid systemic toxicities. Here we show T cells can be armored with membrane-bound cytokines with surface expression regulated using drug-responsive domains (DRDs) developed from the 260-amino acid protein human carbonic anhydrase 2 (CA2).

View Article and Find Full Text PDF

Background: Alkaline phosphatase (ALP) declines and pain responses can occur during radium-223 (Ra) treatment, but their association with treatment outcomes is unclear.

Methods: For patients with metastatic castration-resistant prostate cancer treated with Ra in the REASSURE study, we investigated whether ALP decline (Week 12) and/or pain response (during treatment) are associated with improved overall survival (OS). The Brief Pain Inventory-Short Form (BPI-SF) was used to assess pain at baseline and pain response (in patients with baseline BPI-SF score ≥2).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!